These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1666899)

  • 1. Recurrent Cushing's disease with low adrenal androgen production.
    Louard RJ; Gelfand RA
    J Endocrinol Invest; 1991 Dec; 14(11):965-9. PubMed ID: 1666899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen secretion in ectopic ACTH syndrome and in Cushing's disease: modifications before and after surgery.
    Barbetta L; Dall'Asta C; Re T; Colombo P; Travaglini P; Ambrosi B
    Horm Metab Res; 2001 Oct; 33(10):596-601. PubMed ID: 11607879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissociated recovery of cortisol and dehydroepiandrosterone sulphate after treatment for Cushing's syndrome.
    Kleiber H; Rey F; Temler E; Gomez F
    J Endocrinol Invest; 1991 Jun; 14(6):489-92. PubMed ID: 1663528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of adrenal androgen and cortisol secretion in Cushing's syndrome.
    Cunningham SK; McKenna TJ
    Clin Endocrinol (Oxf); 1994 Dec; 41(6):795-800. PubMed ID: 7889616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of ketoconazole in the treatment of Cushing's syndrome.
    Loli P; Berselli ME; Tagliaferri M
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1365-71. PubMed ID: 3023421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation between plasma adrenal androgens and cortisol in Cushing's disease and ectopic ACTH-producing tumour: relation to adrenarche.
    Hauffa BP; Kaplan SL; Grumbach MM
    Lancet; 1984 Jun; 1(8391):1373-6. PubMed ID: 6145833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum dehydroepiandrosterone sulfate in Cushing's syndrome.
    Yamaji T; Ishibashi M; Sekihara H; Itabashi A; Yanaihara T
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1164-8. PubMed ID: 6238041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of dissociation of cortisol and adrenal androgen secretion after removal of adrenocortical adenoma in patients with Cushing's syndrome.
    Nawata H; Higuchi K; Yanase T; Takayanagi R; Kato K; Ibayashi H
    Endocrinol Jpn; 1985 Oct; 32(5):691-700. PubMed ID: 2936600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
    Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
    J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marked elevation of serum dehydroepiandrosterone sulphate in Cushing's disease with macronodular adrenocortical hyperplasia.
    Jackson JA; Fachnie JD; Mellinger RC
    J Endocrinol Invest; 1989 Apr; 12(4):269-72. PubMed ID: 2526171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Cushing's syndrome with trilostane (WIN 24,540), an inhibitor of adrenal steroid biosynthesis.
    Komanicky P; Spark RF; Melby JC
    J Clin Endocrinol Metab; 1978 Nov; 47(5):1042-51. PubMed ID: 233687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour.
    Flecchia D; Mazza E; Carlini M; Blatto A; Olivieri F; Serra G; Camanni F; Messina M
    Clin Endocrinol (Oxf); 1995 Feb; 42(2):129-34. PubMed ID: 7704956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased dehydroepiandrosterone sulfate in pigmented nodular adrenal dysplasia.
    Braithwaite SS; Collins S; Prinz RA; Walloch JL; Winters GL
    Clin Chem; 1989 Nov; 35(11):2216-9. PubMed ID: 2531049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRKAR1A-negative familial Cushing's syndrome: two case reports.
    Lim LL; Kitan N; Paramasivam SS; Ratnasingam J; Ibrahim L; Chan SP; Tan AT; Vethakkan SR
    J Med Case Rep; 2015 Dec; 9():277. PubMed ID: 26619967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained remission of Cushing's disease with mitotane and pituitary irradiation.
    Schteingart DE; Tsao HS; Taylor CI; McKenzie A; Victoria R; Therrien BA
    Ann Intern Med; 1980 May; 92(5):613-9. PubMed ID: 6247946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenocortical carcinoma with Cushing's syndrome presenting unusual urinary 17-ketosteroid fractionation.
    Watanobe H; Kannari K; Kimura K; Takebe K
    J Endocrinol Invest; 1985 Jun; 8(3):249-52. PubMed ID: 3161933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible ACTH-independent, cortisol-secreting and DHEA-secreting metastatic hepatocellular carcinoma causing Cushing's syndrome.
    Sacerdote A; Inoue T; Thomas N; Bahtiyar G
    BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26698199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of glucagon receptors in adrenal glands of a patient with Cushing's syndrome and ACTH-independent macronodular adrenal hyperplasia.
    de Miguel V; Redal MA; Viale ML; Kahan M; Glerean M; Beskow A; Fainstein Day P
    Medicina (B Aires); 2010; 70(3):254-6. PubMed ID: 20529775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin releasing hormone stimulation test: diagnostic aspects in Cushing's syndrome.
    Boscaro M; Rampazzo A; Sonino N; Merola G; Scanarini M; Mantero F
    J Endocrinol Invest; 1987 Jun; 10(3):297-302. PubMed ID: 3040851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
    Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.